Molecular forms of plasma and urinary adrenomedullin in normal, essential hypertension and chronic renal failure

被引:34
作者
Nishikimi, T [1 ]
Horio, T
Kohmoto, Y
Yoshihara, F
Nagaya, N
Inenaga, T
Saito, M
Teranishi, M
Nakamura, M
Ohrui, M
Kawano, Y
Matsuo, H
Ishimitsu, T
Takishita, S
Matsuoka, H
Kangawa, K
机构
[1] Dokkyo Univ, Sch Med, Dept Hypertens & Cardiorenal Med, Mibu, Tochigi 3210293, Japan
[2] Dokkyo Univ, Sch Med, Dept Hlth Care, Mibu, Tochigi 3210293, Japan
[3] Natl Cardiovasc Ctr, Dept Med, Osaka, Japan
[4] Natl Cardiovasc Ctr, Res Inst, Osaka, Japan
关键词
adrenomedullin; plasma; urine; essential hypertension; chronic renal failure;
D O I
10.1097/00004872-200104000-00014
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Objectives Human adrenomedullin precursor is converted to glycine-extended adrenomedullin (AM-Gly), an intermediate inactive form of adrenomedullin. Subsequently, AM-Gly is converted to active form of mature adrenomeduliin (AM-m), The aim of the present study was to investigate (i) whether sex or age influences plasma and urinary AM-m and AM-Gly levels in normal subjects; (ii) the daytime variability of plasma AM-m and AM-Gly( levels in normal subjects; (iii) AM-m and AM-Gly levels and its ratio in plasma and urine in normal subjects, individuals with essential hypertension (HT), and chronic renal failure (CRF); and (iv) the ratio of AM-m and AM-total (T) in plasma of various veins and aorta. Methods We measured plasma levels and urinary excretions of AM-m, AM-Gly and AM-T (AM-m + AM-Gly) by recently developed immunoradiometric assay in normal subjects (n = 81), HT (n = 28) and CRF (n = 30), We also determined the molecular forms of plasma adrenomedullin taken from various sites during angiography in patients with suspected renovascular hypertension (n = 9). Results There were no differences in plasma and urinary excretions of two molecular forms of adrenomedullin among sexes or ages in normal subjects, There was no daytime variation of plasma two molecular forms of adrenomedullin in normal subjects. Plasma AM-m, AM-Gly and AM-T levels were increased in patients with HT and CRF compared with normal subjects. whereas urinary AM-m, AM-Gly and AM-T excretions were decreased in patients with Hi and CRF compared with normal subjects. Urinary AM-m :AM-T ratios were significantly higher than plasma AM-m :AM-T ratios. Plasma AM-m and AM-T levels taken from various veins were similar, and they were significantly higher than those of aorta, although there were no differences in plasma AM-Gly levels between aorta and veins. Conclusions These results suggest that in normal subjects, and individuals with HT and CRF: (i) plasma and urinary excretions of AM-m and AM-Gly are not affected by age or sex; (ii) AM-m in parallel with AM-Gly is increased; (iii) urine contains a higher percentage of active adrenomedullin than plasma; and (iv) plasma AM-m may be partly metabolized in the lu ng. (C) 2001 Lippincott Williams & Wilkins.
引用
收藏
页码:765 / 773
页数:9
相关论文
共 40 条
[11]   Increased plasma levels of adrenomedullin in patients with pulmonary hypertension [J].
Kakishita, M ;
Nishikimi, T ;
Okano, Y ;
Satoh, T ;
Kyotani, S ;
Nagaya, N ;
Fukushima, K ;
Nakanishi, N ;
Takishita, S ;
Miyata, A ;
Kangawa, K ;
Matsuo, H ;
Kunieda, T .
CLINICAL SCIENCE, 1999, 96 (01) :33-39
[12]  
KAPLAN NK, 1998, CLIN HYPERTENSION, P319
[13]  
KASISKE BL, 1996, BRENNER RECTORS KIDN, P1129
[14]   Hypotensive effect of chronically infused adrenomedullin in conscious Wistar-Kyoto and spontaneously hypertensive rats [J].
Khan, AI ;
Kato, J ;
Kitamura, K ;
Kangawa, K ;
Eto, T .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1997, 24 (02) :139-142
[15]   Effect of chronically infused adrenomedullin in two-kidney, one-clip hypertensive rats [J].
Khan, AI ;
Kato, J ;
Ishiyama, Y ;
Kitamura, K ;
Kangawa, K ;
Eto, T .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 333 (2-3) :187-190
[16]   Plasma and urine levels of adrenomedullin and proadrenomedullin N-terminal 20 peptide in chronic glomerulonephritis [J].
Kinoshita, H ;
Fujimoto, S ;
Kitamura, K ;
Yokota, N ;
Kawamoto, M ;
Tokura, T ;
Hisanaga, S ;
Eto, T .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 34 (01) :114-119
[17]   ADRENOMEDULLIN - A NOVEL HYPOTENSIVE PEPTIDE ISOLATED FROM HUMAN PHEOCHROMOCYTOMA [J].
KITAMURA, K ;
KANGAWA, K ;
KAWAMOTO, M ;
ICHIKI, Y ;
NAKAMURA, S ;
MATSUO, H ;
ETO, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 192 (02) :553-560
[18]   CLONING AND CHARACTERIZATION OF CDNA-ENCODING A PRECURSOR FOR HUMAN ADRENOMEDULLIN [J].
KITAMURA, K ;
SAKATA, J ;
KANGAWA, K ;
KOJIMA, M ;
MATSUO, H ;
ETO, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 194 (02) :720-725
[19]   The intermediate form of glycine-extended adrenomedullin is the major circulating molecular form in human plasma [J].
Kitamura, K ;
Kato, J ;
Kawamoto, M ;
Tanaka, M ;
Chino, N ;
Kangawa, K ;
Eto, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 244 (02) :551-555
[20]   Increased plasma adrenomedullin in acute myocardial infarction [J].
Kobayashi, K ;
Kitamura, K ;
Hirayama, N ;
Date, H ;
Kashiwagi, T ;
Ikushima, I ;
Hanada, Y ;
Nagatomo, Y ;
Takenaga, M ;
Ishikawa, T ;
Imamura, T ;
Koiwaya, Y ;
Eto, T .
AMERICAN HEART JOURNAL, 1996, 131 (04) :676-680